DarioHealth Corp. Securities Investigation
The White Law Group is currently investigating whether brokerage firms improperly recommended and sold investments in DarioHealth Corp. that may have been unsuitable for investors.
The company’s common stock is listed on The Nasdaq Capital Market, or Nasdaq, under the symbol “DRIO.” On March 29, 2017, On March 29, 2017, the company’s last reported sale price for our common stock was $3.99 per share. As of February 28, 2024, the average post offering return was –96.4%.
According to Market Watch, shares of DRIO have declined –71.68% in the past 12 months.
(Note: Investors should check the most recent share price, as it may have changed since this report.)
According to its prospectus, investing in DarioHealth Corp.’s securities is highly speculative and involves a high degree of risk.
DarioHealth Corp Background
DarioHealth Corp. is reportedly a digital health company which offers a user-centric and multi-chronic condition digital therapeutics platform that delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
Broker Responsibilities and Investor Protections
Broker dealers are required to conduct thorough due diligence on any investment they recommend and ensure that all recommendations are suitable for their clients. Firms that fail in this duty may be held liable for investor losses through FINRA arbitration claims.
If a broker or brokerage firm makes an unsuitable investment recommendation or fails to disclose the associated risks adequately, they may be found liable for investment losses in a FINRA arbitration claim. Fortunately, FINRA provides an arbitration forum for investors to resolve such disputes.
Class Action vs. Individual FINRA Arbitration Lawsuit
You may wonder whether a large class action lawsuit is a better litigation option than an individual FINRA arbitration case. The answer depends on many factors, but typically if the loss sustained is large (say larger than $100,000), an individual arbitration claim is likely a better option. Class actions as a recovery option are more appropriate for grouping large numbers of individuals who have small claims – too small to generally pursue individually.
Free Consultation
If you have suffered investment losses in DarioHealth Corp., you may have recovery options. The securities attorneys at The White Law Group offer free consultations and can be reached at 1-888-637-5510.
About The White Law Group
The White Law Group is a national securities fraud, securities arbitration, and investor protection law firm with offices in Chicago, Illinois and Seattle, Washington. The firm represents investors across the country in claims against their brokerage firms.
FAQs – DarioHealth Corp
1. Why is DarioHealth Corp. (DRIO) under investigation?
The White Law Group is investigating whether brokerage firms unsuitably recommended investments in DarioHealth Corp. to their clients. The company’s stock has performed poorly, with an average post-offering return of –96.4% as of February 28, 2024, and a decline of –71.68% over the past 12 months, raising concerns about broker due diligence and risk disclosure.
2. What are the risks of investing in DarioHealth Corp.?
DarioHealth is a digital health company operating in a high-risk, fast-evolving sector. Its securities are considered highly speculative, according to its own prospectus. Risks include rapid market changes, reliance on clinical outcomes, and competitive pressures—all of which may impact performance. Investors in DRIO have seen substantial losses since its public offering.
3. Can I recover my losses from investing in DRIO?
If your broker failed to properly assess your financial situation or did not fully explain the risks associated with investing in DRIO, you may be eligible to recover your losses through a FINRA arbitration claim. The White Law Group offers free consultations to determine if you have a viable case for recovery.
Last modified: June 3, 2025